C12Y 114/13011
Trans-cinnamate 4-monooxygenase
Official title: Trans-cinnamate 4-monooxygenase (1.14.13.11)
C12Y114/13011 (Trans-cinnamate 4-monooxygenase) appears on 11 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 13
- Assignees
- 13
- Inventors
- 29
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism21 May 2024US 11,987,829 B2Les Laboratoires Servier
- Recombinant host cell for biosynthetic production31 Dec 2019US 10,519,472 B2Rhodia Operations
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof5 Dec 2017US 9,834,793 B2Evolva SA
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof2 Aug 2016US 9,404,129 B2Evolva SA
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism12 Dec 2024US 2024/0409976 A1Les Laboratoires Servier
- Engineering Bacteria for Ferulic Acid Production, Preparation Method and Use Thereof17 Feb 2022US 2022/0049235 A1Cas Center for Excellence In Molecular Plant Sciences
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism10 Feb 2022US 2022/0042061 A1Les Laboratoires Servier
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof17 Dec 2015US 2015/0361455 A1Evolva SA
- Recombinant host cell for biosynthetic production12 Nov 2015US 2015/0322465 A1Rhodia Operations
Most cited
By later US patents
- Materials and methods for the modification of plant lignin content14US 6,410,718 B1Fletcher Challenge Forests Limited · 2002
- Male-sterile plants, method for obtaining male-sterile plants and recombinant DNA for use therein13US 6,005,167 AMogen International N.V. · 1999
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof6US 8,895,287 B2Evolva SA · 2014
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof2US 9,040,269 B2EVOLA Limited · 2015
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism1US 11,987,829 B2Les Laboratoires Servier · 2024